Close menu




May 25th, 2022 | 10:44 CEST

All eyes on Deutsche Bank and Commerzbank - but Aspermont has the greatest leverage

  • Investments
  • Technology
  • Mining
Photo credits: pixabay.com

The two best-known German banks are currently in demand on the market. Why? The interest rate turnaround means that the typical bread-and-butter business with loans is profitable again. Business picks up when banks have room to manoeuvre with interest rates in positive territory. Also, the increasingly weaker environment for corporate financing at the upper end of the risk scale ensures that banks take on a more critical role as traditional intermediaries. We take a closer look at Commerzbank and Deutsche Bank, but we also have an exciting second-tier stock on our list that could become an insider tip thanks to its unique selling propositions and growth potential.

time to read: 2 minutes | Author: Nico Popp
ISIN: DEUTSCHE BANK AG NA O.N. | DE0005140008 , COMMERZBANK AG | DE000CBK1001 , ASPERMONT LTD | AU000000ASP3

Table of contents:


    Deutsche Bank and Commerzbank: Lagarde is in a good mood

    Deutsche Bank's share price has risen significantly in recent days. However, on a one-year horizon, it still stands at a loss of around 17%. The latest upward trend stems from statements by ECB chief Christine Lagarde, who has held out the prospect of an end to the bond-buying program - in return, interest rates in the eurozone could rise as early as this summer. That is good news for banks: On the one hand, an asset class that had almost been forgotten is coming back to life in the form of bonds, and on the other hand, capital is earning money again.

    Prices beyond EUR 10 are positive for investors; then, the value could go back into an upward trend. However, investors should keep in mind that Deutsche Bank is more of a large tanker than a nimble speedboat. However, there is potential in any case - also with a view to the entire financial sector. Also exciting is the Commerzbank share, where, significantly, Deutsche Bank recently issued a buy recommendation. The reason for the recommendation is the already increased net interest income.

    Aspermont: Financing platform comes at the right time

    Banks and other players in the financial sector need to be aware of the new potential that is emerging. In recent years, large corporations, in particular, have often been driven by short-term profit targets and have positioned themselves leanly. However, once business relationships have fallen asleep, they can no longer be exploited when the sun shines again. The situation is different at Aspermont. The Australian media company, with offices around the globe, publishes Mining Magazine and other venerable publications that are recognized industry journals for the mining sector. What sounds like a somewhat dusty daily newspaper has been digital at Aspermont for many years. It is tailored to the needs of producers, suppliers, and buyers from industry and investors.

    From these long-standing business relationships, Aspermont draws the potential to initiate new business areas effectively. The Company recently announced the Blu Horseshoe platform, allowing investors to participate in rounds of company financing on the Australian Stock Exchange (ASX). The process is digital and transparent, offering investors cost benefits above all. Participating companies benefit because their investor base increases, and the process for investors is greatly simplified. At the same time, the platform aims to democratize direct investments in growth companies - from deals between networks to an open market.


    Aspermont is thus poaching in the territory of brokers and banks. The advantage of this digital business is that it can possibly even be transferred to other markets - growth companies worldwide are looking for capital. High inflation is forcing investors to look for opportunities on the stock market even in economically uncertain times. While traditional banks, such as Commerzbank, invest only to a limited extent in growth projects, at Aspermont, the share of these investments plays a greater role in terms of the expected potential. Investors can see opportunities in this. The Aspermont share currently seems to have found a bottom.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Nico Popp

    At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

    About the author



    Related comments:

    Commented by André Will-Laudien on March 28th, 2024 | 09:00 CET

    Attention: Uranium despite the energy transition! Does this fit together? Plug Power, Nel ASA, Kraken Energy and Renk Group in focus

    • Mining
    • Uranium
    • Energy
    • renewableenergies
    • nuclear

    It feels like a paradox. The EU aims to be largely climate-neutral by 2050. The main focus is on mobility, heat and energy generation. As a core country of the EU, Germany is taking the political lead in the necessary measures. While France, Poland, Finland and the Czech Republic are actively expanding nuclear energy, this form of energy is virtually taboo in many other countries. Germany has been able to increase its renewable energy sources to over 50% with billions in subsidies at the expense of the taxpayer and the price of energy. Yet, Berlin still has to buy cheap electricity from abroad and also use coal and gas to stabilize the grid. It all sounds kind of crazy, but it gets really interesting when the wind isn't blowing and the sun is only to be found behind the clouds. Which shares should be considered in this mixed situation?

    Read

    Commented by Fabian Lorenz on March 28th, 2024 | 08:55 CET

    Shares on a high: Up to 300% with Canopy Growth, Super Micro Computer, Aspermont

    • Technology
    • Digitization
    • Cannabis

    Is the German cannabis market on the verge of a tenfold increase? The head of Canopy Growth thinks so. The Company wants to profit from the boom. Canopy shares have already benefited and more than doubled. What are the Company's plans here in Germany? Super Micro Computer shares have already multiplied, but analysts remain bullish. Growth is expected to remain high. Aspermont offers a hot turnaround story. The B2B media company for the raw materials industry has freed itself from legacy burdens and now aims to grow more strongly again. Analysts see a high free cash flow and 300% share price potential!

    Read

    Commented by Juliane Zielonka on March 28th, 2024 | 08:50 CET

    Rheinmetall, Almonty Industries, Bayer AG - Arming up for defense with these stocks

    • Mining
    • Tungsten
    • armaments
    • Pharma

    The European Union is providing the defense group Rheinmetall with a total of EUR 130 million for ammunition production. The German company is one of six EU projects that are being funded in a special program to stockpile enough artillery pieces and secure supply chains. Here, Almonty Industries comes into play. Almonty specializes in the exploration, extraction and production of tungsten in two European countries, including Spain and Portugal. Tungsten is used in particular for ammunition. Almonty Industries also operates five mining projects, one of which is the largest tungsten project in South Korea. The increasing demand for the critical metal will soon cause the price of tungsten to skyrocket, as defense is becoming increasingly important for the countries and continents involved in the face of geopolitical tensions worldwide. Defense is also a topic at Bayer. The cancer drug Nubeqa supports the body's immune system in the fight against prostate cancer. Following the recent pipeline flop with Asundexian, the drug has great blockbuster potential and could bring billions of euros into the Company's coffers. Read more about why this is so important for Bayer at the moment.

    Read